- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Preimplantation Genetic Diagnosis (PGD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Preimplantation Genetic Diagnosis (PGD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Preimplantation Genetic Diagnosis (PGD) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Preimplantation Genetic Diagnosis (PGD) market has been segmented into:
Chromosomal Abnormalities
Gender Selection
X-linked Diseases
Aneuploidy
Single Gene Disorders
Others
By Application, Preimplantation Genetic Diagnosis (PGD) has been segmented into:
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Preimplantation Genetic Diagnosis (PGD) market presented in the report. This section sheds light on the sales growth of different regional and country-level Preimplantation Genetic Diagnosis (PGD) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Preimplantation Genetic Diagnosis (PGD) market.
The report offers in-depth assessment of the growth and other aspects of the Preimplantation Genetic Diagnosis (PGD) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Preimplantation Genetic Diagnosis (PGD) Market Share Analysis
Preimplantation Genetic Diagnosis (PGD) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Preimplantation Genetic Diagnosis (PGD) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Preimplantation Genetic Diagnosis (PGD) sales, revenue and market share for each player covered in this report.
The major players covered in Preimplantation Genetic Diagnosis (PGD) are:
Illumina
Takara Bio
PerkinElmer
Thermo Fisher
Natera
Agilent Technologies
Yikon Genomics
Abbott Laboratories
Coopersurgical
Oxford Gene Technology
Combimatrix
Quest Diagnostics
Progenesis
Genea Limited
Invicta Genetics
Beijing Genomics Institute
Bioarray
Invitae
Among other players domestic and global, Preimplantation Genetic Diagnosis (PGD) market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Preimplantation Genetic Diagnosis (PGD) Market Overview
1.1 Product Overview and Scope of Preimplantation Genetic Diagnosis (PGD)
1.2 Classification of Preimplantation Genetic Diagnosis (PGD) by Type
1.2.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type in 2019
1.2.3 Chromosomal Abnormalities
1.2.4 Gender Selection
1.2.5 X-linked Diseases
1.2.6 Aneuploidy
1.2.7 Single Gene Disorders
1.2.8 Others
1.3 Global Preimplantation Genetic Diagnosis (PGD) Market by Application
1.3.1 Overview: Global Preimplantation Genetic Diagnosis (PGD) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals, Diagnostic Labs, and Service Providers
1.3.4 Research Laboratories & Academic Institutes
1.4 Global Preimplantation Genetic Diagnosis (PGD) Market by Regions
1.4.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Preimplantation Genetic Diagnosis (PGD) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Preimplantation Genetic Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Preimplantation Genetic Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Preimplantation Genetic Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Preimplantation Genetic Diagnosis (PGD) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Preimplantation Genetic Diagnosis (PGD) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina SWOT Analysis
2.1.4 Illumina Product and Services
2.1.5 Illumina Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takara Bio
2.2.1 Takara Bio Details
2.2.2 Takara Bio Major Business
2.2.3 Takara Bio SWOT Analysis
2.2.4 Takara Bio Product and Services
2.2.5 Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.3 PerkinElmer
2.3.1 PerkinElmer Details
2.3.2 PerkinElmer Major Business
2.3.3 PerkinElmer SWOT Analysis
2.3.4 PerkinElmer Product and Services
2.3.5 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher
2.4.1 Thermo Fisher Details
2.4.2 Thermo Fisher Major Business
2.4.3 Thermo Fisher SWOT Analysis
2.4.4 Thermo Fisher Product and Services
2.4.5 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Natera
2.5.1 Natera Details
2.5.2 Natera Major Business
2.5.3 Natera SWOT Analysis
2.5.4 Natera Product and Services
2.5.5 Natera Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business
2.6.3 Agilent Technologies Product and Services
2.6.4 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Yikon Genomics
2.7.1 Yikon Genomics Details
2.7.2 Yikon Genomics Major Business
2.7.3 Yikon Genomics Product and Services
2.7.4 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business
2.8.3 Abbott Laboratories Product and Services
2.8.4 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Coopersurgical
2.9.1 Coopersurgical Details
2.9.2 Coopersurgical Major Business
2.9.3 Coopersurgical Product and Services
2.9.4 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Oxford Gene Technology
2.10.1 Oxford Gene Technology Details
2.10.2 Oxford Gene Technology Major Business
2.10.3 Oxford Gene Technology Product and Services
2.10.4 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Combimatrix
2.11.1 Combimatrix Details
2.11.2 Combimatrix Major Business
2.11.3 Combimatrix Product and Services
2.11.4 Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Quest Diagnostics
2.12.1 Quest Diagnostics Details
2.12.2 Quest Diagnostics Major Business
2.12.3 Quest Diagnostics Product and Services
2.12.4 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.13 Progenesis
2.13.1 Progenesis Details
2.13.2 Progenesis Major Business
2.13.3 Progenesis Product and Services
2.13.4 Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.14 Genea Limited
2.14.1 Genea Limited Details
2.14.2 Genea Limited Major Business
2.14.3 Genea Limited Product and Services
2.14.4 Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.15 Invicta Genetics
2.15.1 Invicta Genetics Details
2.15.2 Invicta Genetics Major Business
2.15.3 Invicta Genetics Product and Services
2.15.4 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.16 Beijing Genomics Institute
2.16.1 Beijing Genomics Institute Details
2.16.2 Beijing Genomics Institute Major Business
2.16.3 Beijing Genomics Institute Product and Services
2.16.4 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bioarray
2.17.1 Bioarray Details
2.17.2 Bioarray Major Business
2.17.3 Bioarray Product and Services
2.17.4 Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
2.18 Invitae
2.18.1 Invitae Details
2.18.2 Invitae Major Business
2.18.3 Invitae Product and Services
2.18.3 Invitae Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Preimplantation Genetic Diagnosis (PGD) Players Market Share
3.2.2 Top 10 Preimplantation Genetic Diagnosis (PGD) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue and Market Share by Regions
4.2 North America Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.3 Europe Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.5 South America Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
5 North America Preimplantation Genetic Diagnosis (PGD) Revenue by Countries
5.1 North America Preimplantation Genetic Diagnosis (PGD) Revenue by Countries (2015-2020)
5.2 USA Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
5.3 Canada Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
5.4 Mexico Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6 Europe Preimplantation Genetic Diagnosis (PGD) Revenue by Countries
6.1 Europe Preimplantation Genetic Diagnosis (PGD) Revenue by Countries (2015-2020)
6.2 Germany Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.3 UK Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.4 France Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.5 Russia Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
6.6 Italy Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue by Countries
7.1 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue by Countries (2015-2020)
7.2 China Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.3 Japan Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.4 Korea Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.5 India Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
8 South America Preimplantation Genetic Diagnosis (PGD) Revenue by Countries
8.1 South America Preimplantation Genetic Diagnosis (PGD) Revenue by Countries (2015-2020)
8.2 Brazil Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
8.3 Argentina Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Preimplantation Genetic Diagnosis (PGD) by Countries
9.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9.3 UAE Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9.4 Egypt Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
9.5 South Africa Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue and Market Share by Type (2015-2020)
10.2 Global Preimplantation Genetic Diagnosis (PGD) Market Forecast by Type (2019-2024)
10.3 Chromosomal Abnormalities Revenue Growth Rate (2015-2025)
10.4 Gender Selection Revenue Growth Rate (2015-2025)
10.5 X-linked Diseases Revenue Growth Rate (2015-2025)
10.6 Aneuploidy Revenue Growth Rate (2015-2025)
10.7 Single Gene Disorders Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Preimplantation Genetic Diagnosis (PGD) Market Segment by Application
11.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2015-2020)
11.2 Preimplantation Genetic Diagnosis (PGD) Market Forecast by Application (2019-2024)
11.3 Maternity Centers & Fertility Clinics Revenue Growth (2015-2020)
11.4 Hospitals, Diagnostic Labs, and Service Providers Revenue Growth (2015-2020)
11.5 Research Laboratories & Academic Institutes Revenue Growth (2015-2020)
12 Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast (2021-2025)
12.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast (2021-2025)
12.2 Global Preimplantation Genetic Diagnosis (PGD) Market Forecast by Regions (2021-2025)
12.3 North America Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.4 Europe Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.6 South America Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Preimplantation Genetic Diagnosis (PGD) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Preimplantation Genetic Diagnosis (PGD) Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Illumina Corporate Information, Location and Competitors
Table 7. Illumina Preimplantation Genetic Diagnosis (PGD) Major Business
Table 8. Illumina Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 9. Illumina SWOT Analysis
Table 10. Illumina Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 11. Illumina Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Takara Bio Corporate Information, Location and Competitors
Table 13. Takara Bio Preimplantation Genetic Diagnosis (PGD) Major Business
Table 14. Takara Bio Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2018-2019)
Table 15. Takara Bio SWOT Analysis
Table 16. Takara Bio Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 17. Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. PerkinElmer Corporate Information, Location and Competitors
Table 19. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Major Business
Table 20. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 21. PerkinElmer SWOT Analysis
Table 22. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 23. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Thermo Fisher Corporate Information, Location and Competitors
Table 25. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Major Business
Table 26. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 27. Thermo Fisher SWOT Analysis
Table 28. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 29. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Natera Corporate Information, Location and Competitors
Table 31. Natera Preimplantation Genetic Diagnosis (PGD) Major Business
Table 32. Natera Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 33. Natera SWOT Analysis
Table 34. Natera Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 35. Natera Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Agilent Technologies Corporate Information, Location and Competitors
Table 37. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Major Business
Table 38. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 39. Agilent Technologies SWOT Analysis
Table 40. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 41. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Yikon Genomics Corporate Information, Location and Competitors
Table 43. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Major Business
Table 44. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 45. Yikon Genomics SWOT Analysis
Table 46. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 47. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Abbott Laboratories Corporate Information, Location and Competitors
Table 49. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Major Business
Table 50. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 51. Abbott Laboratories SWOT Analysis
Table 52. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 53. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Coopersurgical Corporate Information, Location and Competitors
Table 55. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Major Business
Table 56. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 57. Coopersurgical SWOT Analysis
Table 58. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 59. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Oxford Gene Technology Corporate Information, Location and Competitors
Table 61. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Major Business
Table 62. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 63. Oxford Gene Technology SWOT Analysis
Table 64. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 65. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Combimatrix Corporate Information, Location and Competitors
Table 67. Combimatrix Preimplantation Genetic Diagnosis (PGD) Major Business
Table 68. Combimatrix Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 69. Combimatrix SWOT Analysis
Table 70. Combimatrix Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 71. Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Quest Diagnostics Corporate Information, Location and Competitors
Table 73. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Major Business
Table 74. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 75. Quest Diagnostics SWOT Analysis
Table 76. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 77. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Progenesis Corporate Information, Location and Competitors
Table 79. Progenesis Preimplantation Genetic Diagnosis (PGD) Major Business
Table 80. Progenesis Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 81. Progenesis SWOT Analysis
Table 82. Progenesis Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 83. Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Genea Limited Corporate Information, Location and Competitors
Table 85. Genea Limited Preimplantation Genetic Diagnosis (PGD) Major Business
Table 86. Genea Limited Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 87. Genea Limited SWOT Analysis
Table 88. Genea Limited Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 89. Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Invicta Genetics Corporate Information, Location and Competitors
Table 91. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Major Business
Table 92. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 93. Invicta Genetics SWOT Analysis
Table 94. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 95. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Beijing Genomics Institute Corporate Information, Location and Competitors
Table 97. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Major Business
Table 98. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 99. Beijing Genomics Institute SWOT Analysis
Table 100. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 101. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Bioarray Corporate Information, Location and Competitors
Table 103. Bioarray Preimplantation Genetic Diagnosis (PGD) Major Business
Table 104. Bioarray Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 105. Bioarray SWOT Analysis
Table 106. Bioarray Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 107. Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Invitae Preimplantation Genetic Diagnosis (PGD) Type and Application
Table 109. Invitae Preimplantation Genetic Diagnosis (PGD) Major Business
Table 110. Invitae Preimplantation Genetic Diagnosis (PGD) Total Revenue (USD Million) (2017-2018)
Table 111. Invitae SWOT Analysis
Table 112. Invitae Preimplantation Genetic Diagnosis (PGD) Product and Solutions
Table 113. Invitae Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) by Players (2015-2020)
Table 115. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Players (2015-2020)
Table 116. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) by Regions (2015-2020)
Table 117. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Regions (2015-2020)
Table 118. North America Preimplantation Genetic Diagnosis (PGD) Revenue by Countries (2015-2020)
Table 119. North America Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Table 120. Europe Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2015-2020)
Table 121. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2015-2020)
Table 122. South America Preimplantation Genetic Diagnosis (PGD) Revenue by Countries (2015-2020)
Table 123. South America Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Table 124. Middle East and Africa Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) by Countries (2015-2020)
Table 125. Middle East and Africa Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Table 126. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) by Type (2015-2020)
Table 127. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Type (2015-2020)
Table 128. Global Preimplantation Genetic Diagnosis (PGD) Revenue Forecast by Type (2021-2025)
Table 129. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Application (2015-2020)
Table 130. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Application (2015-2020)
Table 131. Global Preimplantation Genetic Diagnosis (PGD) Revenue Forecast by Application (2021-2025)
Table 132. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Preimplantation Genetic Diagnosis (PGD) Picture
Figure 2. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type in 2019
Figure 3. Chromosomal Abnormalities Picture
Figure 4. Gender Selection Picture
Figure 5. X-linked Diseases Picture
Figure 6. Aneuploidy Picture
Figure 7. Single Gene Disorders Picture
Figure 8. Others Picture
Figure 9. Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application in 2019
Figure 10. Maternity Centers & Fertility Clinics Picture
Figure 11. Hospitals, Diagnostic Labs, and Service Providers Picture
Figure 12. Research Laboratories & Academic Institutes Picture
Figure 13. Global Preimplantation Genetic Diagnosis (PGD) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Preimplantation Genetic Diagnosis (PGD) Revenue Market Share in 2019
Figure 22. Global Top 10 Players Preimplantation Genetic Diagnosis (PGD) Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Regions (2015-2020)
Figure 26. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Regions in 2018
Figure 27. North America Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 28. Europe Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 30. South America Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 32. North America Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 33. North America Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 34. USA Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 35. Canada Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 37. Europe Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 39. Germany Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 40. UK Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 41. France Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 42. Russia Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 43. Italy Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 46. China Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 47. Japan Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 48. Korea Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 49. India Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 51. South America Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 52. South America Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 53. Brazil Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 58. UAE Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Preimplantation Genetic Diagnosis (PGD) Revenue and Growth Rate (2015-2020)
Figure 61. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Type (2015-2020)
Figure 62. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Type in 2019
Figure 63. Global Preimplantation Genetic Diagnosis (PGD) Market Share Forecast by Type (2021-2025)
Figure 64. Global Chromosomal Abnormalities Revenue Growth Rate (2015-2020)
Figure 65. Global Gender Selection Revenue Growth Rate (2015-2020)
Figure 66. Global X-linked Diseases Revenue Growth Rate (2015-2020)
Figure 67. Global Aneuploidy Revenue Growth Rate (2015-2020)
Figure 68. Global Single Gene Disorders Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Application (2015-2020)
Figure 71. Global Preimplantation Genetic Diagnosis (PGD) Revenue Share by Application in 2019
Figure 72. Global Preimplantation Genetic Diagnosis (PGD) Market Share Forecast by Application (2021-2025)
Figure 73. Global Maternity Centers & Fertility Clinics Revenue Growth Rate (2015-2020)
Figure 74. Global Hospitals, Diagnostic Labs, and Service Providers Revenue Growth Rate (2015-2020)
Figure 75. Global Research Laboratories & Academic Institutes Revenue Growth Rate (2015-2020)
Figure 76. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Preimplantation Genetic Diagnosis (PGD) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 80. Europe Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 82. South America Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Preimplantation Genetic Diagnosis (PGD) Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
